-
Life Sciences & Healthcare newsletter, June 2024
This month’s Life Sciences & Healthcare newsletter bring you a short overview of how off-label use of medicinal products is regulated in the Baltics. This is especially interesting in the light of the recent judgement of the European Court of Justice on off-label use of medicinal products. Risk-benefit balance includes risks resulting from off-label use The […]
-
Life Sciences & Healthcare newsletter, April 2024
This month’s Life Sciences & Healthcare newsletter focuses on the distance selling of medicinal products. In February, the Court of Justice of the European Union made a fundamental decision concerning the legality of distance selling of over-the-counter (OTC) medicinal products. At the same time, in all of the Baltic States the possibilities under the brand […]
-
Life Sciences & Healthcare newsletter, February 2024
This month’s Life Sciences & Healthcare newsletter focuses on the aspects of competition law. All the competition authorities in the Baltics keep a keen eye on the healthcare sector, which means that market participants should also keep up with possible changes in the authorities’ practices and approaches. The European Union Commission’s report on enforcement of competition […]